Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. [electronic resource]
Producer: 20031007Description: 538-43 p. digitalISSN:- 0002-9149
- Aged
- Analysis of Variance
- Anticholesteremic Agents -- administration & dosage
- Apolipoprotein A-I -- blood
- Apolipoprotein A-II -- blood
- Apolipoproteins B -- blood
- Apolipoproteins C -- blood
- Apolipoproteins E -- blood
- Caproates -- administration & dosage
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Hypercholesterolemia -- blood
- Hypertriglyceridemia -- blood
- Male
- Middle Aged
- Treatment Outcome
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.